<div>
<div>
<div>
<p>Sulfur-Fluoride Exchange (SuFEx) has emerged as the new generation of click chemistry. We
report here a SuFEx-enabled approach exploiting the “sleeping beauty” phenomenon of sulfur
fluoride compounds in the context of the serendipitous discovery of selective covalent human
neutrophil elastase (hNE) inhibitors. Evaluation of an ever-growing collection of SuFExable
compounds toward various biological assays unexpectedly yielded a selective and covalent hNE
inhibitor, benzene-1,2-disulfonyl fluoride. Derivatization of the initial hit led to a better agent, 2-
triflyl benzenesulfonyl fluoride, itself made through a SuFEx trifluoromethylation process, with IC50
= 1.1 μM and ~200-fold selectivity over the homologous neutrophil serine protease, cathepsin G.
The optimized probe only modified active hNE and not its denatured form, setting another
example of the “sleeping beauty” phenomenon of sulfur fluoride capturing agents for the discovery
of covalent medicines.
</p>
</div>
</div>
</div>